- Home
- IRON vs DHT Comparison
IRON vs DHT Comparison
Compare IRON & DHT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- DHT
- Stock Information
- Founded
- IRON 2017
- DHT 2005
- Country
- IRON United States
- DHT Bermuda
- Employees
- IRON N/A
- DHT N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- DHT Marine Transportation
- Sector
- IRON Health Care
- DHT Consumer Discretionary
- Exchange
- IRON Nasdaq
- DHT Nasdaq
- Market Cap
- IRON 1.9B
- DHT 1.6B
- IPO Year
- IRON N/A
- DHT 2005
- Fundamental
- Price
- IRON $42.17
- DHT $10.42
- Analyst Decision
- IRON Strong Buy
- DHT Strong Buy
- Analyst Count
- IRON 10
- DHT 3
- Target Price
- IRON $83.80
- DHT $13.67
- AVG Volume (30 Days)
- IRON 608.5K
- DHT 2.3M
- Earning Date
- IRON 05-08-2025
- DHT 05-13-2025
- Dividend Yield
- IRON N/A
- DHT 9.13%
- EPS Growth
- IRON N/A
- DHT 13.13
- EPS
- IRON N/A
- DHT 1.12
- Revenue
- IRON N/A
- DHT $571,773,000.00
- Revenue This Year
- IRON N/A
- DHT N/A
- Revenue Next Year
- IRON N/A
- DHT $24.33
- P/E Ratio
- IRON N/A
- DHT $9.30
- Revenue Growth
- IRON N/A
- DHT 2.00
- 52 Week Low
- IRON $25.64
- DHT $8.67
- 52 Week High
- IRON $68.73
- DHT $12.80
- Technical
- Relative Strength Index (RSI)
- IRON 42.98
- DHT 51.07
- Support Level
- IRON $39.20
- DHT $9.86
- Resistance Level
- IRON $41.41
- DHT $10.39
- Average True Range (ATR)
- IRON 4.37
- DHT 0.45
- MACD
- IRON 0.09
- DHT 0.02
- Stochastic Oscillator
- IRON 54.14
- DHT 82.18
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company that is dedicated to transforming the lives of patients with hematologic disorders. The company is building a portfolio of inventive therapeutic candidates that affect fundamental pathways of red blood cell biology. Disc Medicine is committed to developing treatments that empower and bring hope to the many patients who suffer from hematologic disease. The Company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis.
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. It is an independent crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. It generates revenues from time charter and spot market operations. Its fleets consist of very large crude carriers known as VLCCs that range in size from 270,000 to 320,000 deadweight tons. Geographically, DHT operates in Monaco, Oslo, Norway, and Singapore. The company generates the majority of its revenue from the shipping revenues.